Inventor · disambiguated record
Keith Foster
Also filed as: FOSTER KEITH · FOSTER KEITH A · FOSTER KEITH ALAN
54 granted patents·32 pending applications·2,174 citations·filing 1996–2022
99Inventor score
Files withSYNTAXIN LTD22IPSEN BIOINNOVATION LTD12FOSTER KEITH11HEALTH PROT AGENCY10FOSTER KEITH ALAN5
Top patents by PatentIndex Score
86 records- 0198US7659092B2Fusion proteinsSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·58 cites·5 claims
- 0298US7192596B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2002·Granted Mar 20, 2007·160 cites·42 claims
- 0398US6962703B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsHEALTH PROT AGENCY·Filed 2002·Granted Nov 8, 2005·111 cites·29 claims
- 0498US6461617B1Recombinant toxin fragmentsMICROBIOLOGICAL RES AUTHORITY·Filed 1999·Granted Oct 8, 2002·229 cites·10 claims
- 0598US5989545AClostridial toxin derivatives able to modify peripheral sensory afferent functionsSPEYWOOD LAB LTD·Filed 1996·Granted Nov 23, 1999·620 cites·43 claims
- 0697US7892560B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsSYNTAXIN LTD·Filed 2007·Granted Feb 22, 2011·32 cites·4 claims
- 0797US7887810B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsSYNTAXIN LTD·Filed 2007·Granted Feb 15, 2011·32 cites·9 claims
- 0897US7658933B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2007·Granted Feb 9, 2010·57 cites·4 claims
- 0997US6632440B1Methods and compounds for the treatment of mucus hypersecretionHEALTH PROT AGENCY·Filed 1999·Granted Oct 14, 2003·263 cites·19 claims
- 1097US6395513B1Clostridial toxin derivatives able to modify peripheral sensory afferent functionsSPEYWOOD LAB LTD·Filed 1999·Granted May 28, 2002·162 cites·7 claims
- 1196US8067200B2Fusion proteinsFOSTER KEITH·Filed 2005·Granted Nov 29, 2011·43 cites·35 claims
- 1296US7727538B2Methods and compounds for the treatment of mucus hypersecretionSYNTAXIN LTD·Filed 2006·Granted Jun 1, 2010·22 cites·21 claims
- 1395US8603779B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2012·Granted Dec 10, 2013·23 cites·15 claims
- 1495US8187834B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2005·Granted May 29, 2012·33 cites·12 claims
- 1594US7897158B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2007·Granted Mar 1, 2011·11 cites·17 claims
- 1693US8778634B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2012·Granted Jul 15, 2014·11 cites·8 claims
- 1793US8399400B2Fusion proteinsFOSTER KEITH·Filed 2010·Granted Mar 19, 2013·13 cites·23 claims
- 1893US8399401B2Fusion proteinsFOSTER KEITH·Filed 2011·Granted Mar 19, 2013·18 cites·36 claims
- 1992US9243301B2Fusion proteinsFOSTER KEITH·Filed 2012·Granted Jan 26, 2016·15 cites·2 claims
- 2092US8940870B2Fusion proteinsSYNTAXIN LTD·Filed 2013·Granted Jan 27, 2015·11 cites·28 claims
- 2192US8512984B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2011·Granted Aug 20, 2013·19 cites·17 claims
- 2292US8158132B2Clostridial toxin derivatives able to modify peripheral sensory afferent functionsFOSTER KEITH ALAN·Filed 2005·Granted Apr 17, 2012·7 cites·20 claims
- 2392US8124074B2Fusion proteinsFOSTER KEITH ALAN·Filed 2005·Granted Feb 28, 2012·16 cites·25 claims
- 2491US7674470B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2005·Granted Mar 9, 2010·13 cites·30 claims
- 2590US10226433B2Use of cannabinoids in the treatment of degenerative skeletal muscle diseasesGW RES LTD·Filed 2015·Granted Mar 12, 2019·15 cites·4 claims
- 2690US8372615B2Fusion proteinsSYNTAXIN LTD·Filed 2012·Granted Feb 12, 2013·7 cites·24 claims
- 2790US8012479B2Recombinant toxin fragmentsHEALTH PROT AGENCY·Filed 2009·Granted Sep 6, 2011·4 cites·16 claims
- 2889US8012491B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 6, 2011·6 cites·10 claims
- 2989US7384645B2Outer membrane vesicles from gram negative bacteria and use as a vaccineHEALTH PROT AGENCY·Filed 2002·Granted Jun 10, 2008·45 cites·4 claims
- 3088US7208466B1Use of a lectin or conjugates for modulation of c-fibre activityHEALTH PROT AGENCY·Filed 2000·Granted Apr 24, 2007·31 cites·4 claims
- 3187US9474807B2Non-cytotoxic protein conjugatesIPSEN BIOINNOVATION LTD·Filed 2014·Granted Oct 25, 2016·4 cites·8 claims
- 3287US9072736B2Treatment of painFOSTER KEITH·Filed 2012·Granted Jul 7, 2015·8 cites·22 claims
- 3387US8124405B2Fusion proteinsFOSTER KEITH ALAN·Filed 2007·Granted Feb 28, 2012·6 cites·7 claims
- 3487US8017134B2Recombinant toxin fragmentsSYNTAXIN LTD·Filed 2009·Granted Sep 13, 2011·5 cites·12 claims
- 3585US8956847B2Fusion proteinsSYNTAXIN LTD·Filed 2013·Granted Feb 17, 2015·3 cites·25 claims
- 3685US8454976B2Recombinant toxin fragmentsSHONE CLIFFORD CHARLES·Filed 2008·Granted Jun 4, 2013·5 cites·18 claims
- 3784US8790897B2Treatment of mucus hypersecretionQUINN CONRAD PADRAIG·Filed 2007·Granted Jul 29, 2014·6 cites·14 claims
- 3883US9139635B2Non-cytotoxic protein conjugatesFOSTER KEITH·Filed 2011·Granted Sep 22, 2015·4 cites·12 claims
- 3983US9012195B2Non-cytotoxic protein conjugatesSYNTAXIN LTD·Filed 2013·Granted Apr 21, 2015·5 cites·21 claims
- 4083US7193066B1Preparation of highly pure toxin fragmentsHEALTH PROT AGENCY·Filed 2000·Granted Mar 20, 2007·23 cites·10 claims
- 4181US11944688B2Biologically active compoundsSUTURA THERAPEUTICS LTD·Filed 2022·Granted Apr 2, 2024·1 cites·26 claims
- 4279US10619146B2Non-cytotoxic protein conjugatesIPSEN BIOINNOVATION LTD·Filed 2016·Granted Apr 14, 2020·1 cites·12 claims
- 4377US10113159B2Suppression of cancerIPSEN BIOINNOVATION LTD·Filed 2014·Granted Oct 30, 2018·2 cites·22 claims
- 4476US9006395B2Recombinant toxin fragmentsSHONE CLIFFORD CHARLES·Filed 2010·Granted Apr 14, 2015·1 cites·8 claims
- 4576US8852603B2Inhibition of secretion from non-neuronal cellsFOSTER KEITH ALAN·Filed 2012·Granted Oct 7, 2014·3 cites·6 claims
- 4675US9849163B2Modified non-cytotoxic proteasesCHADDOCK JOHN ANDREW·Filed 2009·Granted Dec 26, 2017·3 cites·5 claims
- 4774US12060553B2Evolution of BoNT peptidasesHARVARD COLLEGE·Filed 2018·Granted Aug 13, 2024·1 cites·20 claims
- 4871US8796216B2Suppression of neuroendocrine diseasesJOHNSTONE STEPHEN·Filed 2010·Granted Aug 5, 2014·4 cites·8 claims
- 4970US11248219B2Fusion proteins comprising a non-cytotoxic protease, a translocation domain, and a targeting moiety that binds a galanin receptor and methods for treating, preventing or ameliorating pain using such fusion proteinsIPSEN BIOINNOVATION LTD·Filed 2019·Granted Feb 15, 2022·0 cites·9 claims
- 5069US2007248626A1Recombinant toxin fragmentsIPSEN LTD·Filed 2006·Application pending·0 cites
Showing the top 50 of 86 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →